Hospital Acquired Infection Control Market By Product (Sterilant, Disinfectants, and Other Products), By Indication (Hospital Acquired Pneumonia, Bloodstream Infections, Surgical Site Infections, Gastrointestinal Infections, Urinary Tract Infections, and Other Indications), By End User (Hospitals & Intensive Care Units, Ambulatory Surgical & Diagnostic Centers, and Nursing Homes & Maternity Centers), and By Region - Trends, Analysis and Forecast till 2034

Hospital Acquired Infection Control Market size is estimated at USD 4.35 billion in 2024, and is expected to reach USD 6.37 billion by 2034, growing at a CAGR of 4.3% during the forecast period

Hospital Acquired Infection Control is also called as nosocomial infection acquired in a medical setting in the course of medical treatment. The hospital acquired infection meets the criteria such as hospital acquired infection was incubating at the admission but related to a pervious procedure or the admission to different or same health- care facility. The criterion is temporarily associated with admission or procedure at a health- care facility. Hospital acquired infection cannot found on the admission of patient in the hospitals. The HAI can occur after 48 hours when admitted in hospital.

Rise in hospital stay due to chronic disease and surgeries are the major propelling factor for the growth of target market. Additionally, increase in the incidences of the different types of the hospitals acquired infections is the driving factor for the growth of the global hospital acquired infection control market. In 2018, according to the Tehran University of Medical Sciences, the prevalence of hospital-acquired infection (HAI) was around 30.43%. Moreover, innovation technologies implemented in devices that control infection is the boosting factor for the growth of target market. However, lack of awareness regarding to the hospitals acquired infections and hygiene standards is the major restraining factor for the growth of global market. In addition, the stringent regulatory requirements which is the hampering factor for the growth of target market. Nevertheless, the increasing awareness and adopting government policies about controlling hospital acquired infection can create lucrative opportunity for the growth of target market.  

The global hospital acquired infection control market is segmented based on product, indication, end user, and region.

On the basis of product, the global hospital acquired infection control market is segmented into sterilant, disinfectants, and other products. Other product segment is dominating the global market and is expected to maintain its dominance over the forecast period. On the basis of indication, the target market is segmented into hospital acquired pneumonia, bloodstream infections, surgical site infections, gastrointestinal infections, urinary tract infections, and other indications. The hospital acquired pneumonia indication segment is dominating the global market due to rise in number of patients of HAP. Based on end user, the global market is classified into hospitals & intensive care units, ambulatory surgical & diagnostic centers, and nursing homes & maternity centers.

Regional Insights:

Based on region the global hospital acquired infection control market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

The global market in North America region is seen to have a matured growth since this market is showing largest market share over the forecast period due to better adaptation, better healthcare facilities and higher rate of hygiene practices. North America accounts for large scale hospital acquired infection control market share. Asia- Pacific region hospital acquired infection control market is expected to witness fast growth due to rise in adaptation of hospital acquired infection control practice during the forecast period.

Global Hospital Acquired Infection Control Market, By Product:

• Sterilant
• Disinfectants
• Other Products

Global Hospital Acquired Infection Control Market, By Indication:

• Hospital Acquired Pneumonia
• Bloodstream Infections
• Surgical Site Infections
• Gastrointestinal Infections
• Urinary Tract Infections
• Other Indications

Global Hospital Acquired Infection Control Market, By End User:

• Hospitals & Intensive Care Units
• Ambulatory Surgical & Diagnostic Centers
• Nursing Homes & Maternity Centers

Global Hospital Acquired Infection Control Market, By Region:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • U.K.
  • France
  • Russia
  • Italy
  • Spain
  • Netherlands
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • Indonesia
  • Malaysia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • Israel
  • South Africa
  • Rest of Middle East & Africa

The key players operating the global hospital acquired infection control market involves 3M Company, Becton Dickinson and Company, Fortive Corporation, Metall Zug Group (Belimed), Cantel Medical, Getinge AB, Sotera Health, STERIS PLC., S. C. Johnson & Son Inc., and Tuttnauer. Prominent players operating in the target market are focusing on the strategic partnerships as well as launching of the products in order to gain competitive edge in the target market.

• 3M Company
• Becton Dickinson and Company
• Fortive Corporation
• Metall Zug Group (Belimed)
• Cantel Medical
• Getinge AB
• Sotera Health
• STERIS PLC.
• S. C. Johnson & Son Inc.
• Tuttnauer